Financial insights of ZBIO

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total revenue	-	0	-	0
Research and development	60,439,000	55,719,000	34,402,000	43,027,000
General and administrative	16,911,000	15,593,000	13,178,000	12,136,000
Acquired in-process research and development	-	166,672,000	5,000,000	-
Total operating expenses	77,350,000	237,984,000	52,580,000	55,163,000
Loss from operations	-77,350,000	-237,984,000	-52,580,000	-55,163,000
Interest expense on royalty obligation	6,263,000	1,831,750*	-	-
Interest expense on senior secured term loan	368,000	-	-	-
Interest income	3,018,000	6,655,750*	-	-
Other (expense) income, net	-24,000	-7,176,000	1,081,000	2,960,000
Total other income (expense), net	-3,637,000	-2,352,000	1,081,000	2,960,000
Loss before income taxes	-80,987,000	-240,336,000	-51,499,000	-52,203,000
Income tax (benefit) provision	-	106,000	-	20,000
Net loss	-80,987,000	-240,442,000	-51,499,000	-52,223,000
Unrealized (loss) gain on investments	-341,000	79,000	35,000	30,000
Foreign currency translation adjustment	28,000	-74,000	-10,000	-265,000
Comprehensive loss	-81,300,000	-240,437,000	-51,474,000	-52,458,000

Basic EPS	-1.46	-4.528	-1.22	-1.25
Diluted EPS	-1.46	-4.528	-1.22	-1.25
Basic Average Shares	55,624,631	53,094,666	42,159,340	41,865,400
Diluted Average Shares	55,624,631	53,094,666	42,159,340	41,865,400